These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36845321)

  • 1. Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe.
    Moreno-Martos D; Verhamme K; Ostropolets A; Kostka K; Duarte-Sales T; Prieto-Alhambra D; Alshammari TM; Alghoul H; Ahmed WU; Blacketer C; DuVall S; Lai L; Matheny M; Nyberg F; Posada J; Rijnbeek P; Spotnitz M; Sena A; Shah N; Suchard M; Chan You S; Hripcsak G; Ryan P; Morales D
    Wellcome Open Res; 2022; 7():22. PubMed ID: 36845321
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe.
    Morales DR; Ostropolets A; Lai L; Sena A; Duvall S; Suchard M; Verhamme K; Rjinbeek P; Posada J; Ahmed W; Alshammary T; Alghoul H; Alser O; Areia C; Blacketer C; Burn E; Casajust P; You SC; Dawoud D; Golozar A; Gong M; Jonnagaddala J; Lynch K; Matheny M; Minty E; Nyberg F; Uribe A; Recalde M; Reich C; Scheumie M; Shah K; Shah N; Schilling L; Vizcaya D; Zhang L; Hripcsak G; Ryan P; Prieto-Alhambra D; Durate-Salles T; Kostka K
    J Asthma; 2023 Jan; 60(1):76-86. PubMed ID: 35012410
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis.
    Noor FM; Islam MM
    J Community Health; 2020 Dec; 45(6):1270-1282. PubMed ID: 32918645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study.
    Reyes C; Pistillo A; Fernández-Bertolín S; Recalde M; Roel E; Puente D; Sena AG; Blacketer C; Lai L; Alshammari TM; Ahmed WU; Alser O; Alghoul H; Areia C; Dawoud D; Prats-Uribe A; Valveny N; de Maeztu G; Sorlí Redó L; Martinez Roldan J; Lopez Montesinos I; Schilling LM; Golozar A; Reich C; Posada JD; Shah N; You SC; Lynch KE; DuVall SL; Matheny ME; Nyberg F; Ostropolets A; Hripcsak G; Rijnbeek PR; Suchard MA; Ryan P; Kostka K; Duarte-Salles T
    BMJ Open; 2021 Dec; 11(12):e057632. PubMed ID: 34937726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
    Shin EK; Choi HY; Hayes N
    Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2.
    Gómez Antúnez M; Muiño Míguez A; Bendala Estrada AD; Maestro de la Calle G; Monge Monge D; Boixeda R; Ena J; Mella Pérez C; Anton Santos JM; Lumbreras Bermejo C;
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3433-3445. PubMed ID: 33447021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regular Inhaled Corticosteroids Use May Protect Against Severe COVID-19 Outcome in COPD.
    Labor M; Kirui BK; Nyberg F; Vanfleteren LEGW
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1701-1712. PubMed ID: 37576828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS.
    Kostka K; Duarte-Salles T; Prats-Uribe A; Sena AG; Pistillo A; Khalid S; Lai LYH; Golozar A; Alshammari TM; Dawoud DM; Nyberg F; Wilcox AB; Andryc A; Williams A; Ostropolets A; Areia C; Jung CY; Harle CA; Reich CG; Blacketer C; Morales DR; Dorr DA; Burn E; Roel E; Tan EH; Minty E; DeFalco F; de Maeztu G; Lipori G; Alghoul H; Zhu H; Thomas JA; Bian J; Park J; Martínez Roldán J; Posada JD; Banda JM; Horcajada JP; Kohler J; Shah K; Natarajan K; Lynch KE; Liu L; Schilling LM; Recalde M; Spotnitz M; Gong M; Matheny ME; Valveny N; Weiskopf NG; Shah N; Alser O; Casajust P; Park RW; Schuff R; Seager S; DuVall SL; You SC; Song S; Fernández-Bertolín S; Fortin S; Magoc T; Falconer T; Subbian V; Huser V; Ahmed WU; Carter W; Guan Y; Galvan Y; He X; Rijnbeek PR; Hripcsak G; Ryan PB; Suchard MA; Prieto-Alhambra D
    Clin Epidemiol; 2022; 14():369-384. PubMed ID: 35345821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 2019.
    Puebla Neira DA; Watts A; Seashore J; Duarte A; Nishi SP; Polychronopoulou E; Kuo YF; Baillargeon J; Sharma G
    Chronic Obstr Pulm Dis; 2021 Oct; 8(4):517-527. PubMed ID: 34614553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
    Sheikh D; Tripathi N; Chandler TR; Furmanek S; Bordon J; Ramirez JA; Cavallazzi R
    Respir Med; 2022 Jan; 191():106714. PubMed ID: 34915396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain.
    Roel E; Pistillo A; Recalde M; Sena AG; Fernández-Bertolín S; Aragón M; Puente D; Ahmed WU; Alghoul H; Alser O; Alshammari TM; Areia C; Blacketer C; Carter W; Casajust P; Culhane AC; Dawoud D; DeFalco F; DuVall SL; Falconer T; Golozar A; Gong M; Hester L; Hripcsak G; Tan EH; Jeon H; Jonnagaddala J; Lai LYH; Lynch KE; Matheny ME; Morales DR; Natarajan K; Nyberg F; Ostropolets A; Posada JD; Prats-Uribe A; Reich CG; Rivera DR; Schilling LM; Soerjomataram I; Shah K; Shah NH; Shen Y; Spotniz M; Subbian V; Suchard MA; Trama A; Zhang L; Zhang Y; Ryan PB; Prieto-Alhambra D; Kostka K; Duarte-Salles T
    Cancer Epidemiol Biomarkers Prev; 2021 Oct; 30(10):1884-1894. PubMed ID: 34272262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age, sex, race, and regionality on major clinical outcomes of COVID-19 in hospitalized patients in the United States.
    Sundaram SS; Melquist S; Kalgotra P; Srinivasan S; Parasa S; Desai M; Sharma P
    BMC Infect Dis; 2022 Jul; 22(1):659. PubMed ID: 35906558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.
    Schultze A; Walker AJ; MacKenna B; Morton CE; Bhaskaran K; Brown JP; Rentsch CT; Williamson E; Drysdale H; Croker R; Bacon S; Hulme W; Bates C; Curtis HJ; Mehrkar A; Evans D; Inglesby P; Cockburn J; McDonald HI; Tomlinson L; Mathur R; Wing K; Wong AYS; Forbes H; Parry J; Hester F; Harper S; Evans SJW; Quint J; Smeeth L; Douglas IJ; Goldacre B;
    Lancet Respir Med; 2020 Nov; 8(11):1106-1120. PubMed ID: 32979987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes Among Patients Hospitalized With Non-COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada.
    McAlister FA; Chu A; Qiu F; Dong Y; van Diepen S; Youngson E; Yu AYX; de Mestral C; Ross HJ; Austin PC; Lee DS; Kadri SS; Wijeysundera HC;
    JAMA Netw Open; 2023 Jul; 6(7):e2323035. PubMed ID: 37436751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.
    Dessie ZG; Zewotir T
    BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
    J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.